Cargando…
Postmenopausal bleeding: Which endometrial thickness is safe in menopausal hormone therapy users?
Autor principal: | Dreisler, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356352/ https://www.ncbi.nlm.nih.gov/pubmed/35942074 http://dx.doi.org/10.1016/j.crwh.2022.e00431 |
Ejemplares similares
-
Menopausal hormone therapy and ovarian cancer
por: Baber, Rod
Publicado: (2015) -
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same
por: Lambrinoudaki, Irene
Publicado: (2020) -
Dynamic monitoring of menopause hormone therapy and defining the cut-off value of endometrial thickness during uterine bleeding
por: Sheng, Qiu, et al.
Publicado: (2016) -
Menopausal Hormone Therapy, can we safely use it in women with co-morbidities?
por: Shah, Duru
Publicado: (2015) -
Talking about menopause in the workplace
por: Carter, Sarah, et al.
Publicado: (2021)